Publications
Mannix S, Skalicky A, Buse D, Desai P, Sapra S, Ortmeier B, Widnell K, Hareendran A. Measuring the Impact of Migraine for Evaluating Outcomes of Preventive Treatments for Migraine Headaches. Health Qual Life Outcomes. 2016 Oct 6;14(1):143. https://hqlo.biomedcentral.com/articles/10.1186/s12955-016-0542-3
Hareendran A, Mannix S, Skalicky A, Bayliss M, Blumenfeld A, Buse DC, Desai PR, Ortmeier BG, Sapra S. Development and exploration of the content validity of a patient-reported outcome measure to evaluate the impact of migraine- the migraine physical function impact diary (MPFID). Health and Quality of Life Outcomes 2017; 15:224. https://hqlo.biomedcentral.com/articles/10.1186/s12955-017-0799-1
Kawata AK, Hsieh R, Bender R, Shaffer S, Revicki DA, Bayliss M, Buse DC, Desai P, Sapra S, Ortmeier B, Hareendran A. Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary. Headache. 2017 Oct; 57(9):1385-1398. doi: 10.1111/head.13162. Epub 2017 Aug 30.
Goadsby PJ, Reuter U, Hallström Y, Broessner G, Bonner JH, Zhang F, Sapra S, Picard H, Mikol DD, Lenz RA. A controlled trial of erenumab for episodic migraine. New England Journal of Medicine. 2017 Nov 30;377(22):2123-32.
Dodick DW, Ashina M, Brandes JL, Kudrow D, Lanteri-Minet M, Osipova V, Palmer K, Picard H, Mikol DD, Lenz RA. ARISE: a phase 3 randomized trial of erenumab for episodic migraine. Cephalalgia. 2018 May;38(6):1026-37.
Posters and Presentations
Hareendran A, Mannix S, Skalicky AM, Widnell K, Corey-Lisle PK, Sapra S. A Qualitative Study of the Functional Impact of Symptoms on Migraine Patients. Presented at EHMTIC – 2014; September 18-21, 2014; Copenhagen, Denmark.
Skalicky AM, Mannix S, Oko-Osi H, Widnell KL, Hareendran A, Corey-Lisle PK, Sapra S. Developing a Conceptual Model of Patients’ Experience of Migraine. Presented at ISOQOL 2014 21st Annual Conference; October 15-18, 2014; Berlin, Germany.
Hareendran A, Mannix S, Skalicky AM, Widnell K, Corey-Lisle PK, Sapra S. A Qualitative Study of the Functional Impact of Symptoms on Migraine Patients. Presented at EHMTIC – 2014; September 18-21, 2014; Copenhagen, Denmark.
Skalicky AM, Mannix S, Oko-Osi H, Widnell KL, Hareendran A, Corey-Lisle PK, Sapra S. Developing a Conceptual Model of Patients’ Experience of Migraine. Presented at ISOQOL 2014 21st Annual Conference; October 15-18, 2014; Berlin, Germany.
Kawata AK, Sapra S, Desai P, Ortmeier B, Gleeson S, Revicki D, Lipton RB, Bayliss M, Hareendran A. An Anchor-Based Approach to Define an Impaired Day in Migraine Patients Utilizing the Migraine Physical Function Impact Diary (MPFID). Presented at ISPOR 2016 19th Annual European Congress; October 29-November 2, 2016; Vienna, Austria.
Kawata AK, Hsieh R, Hareendran A, Bender R, Shaffer S, Sapra S, Desai P, Bayliss M, Buse DC, Revicki D. Psychometric Properties of the Migraine Physical Function Impact Diary (MPFID). Presented at ISOQOL 2016 23rd Annual Conference; October 19-22, 2016; Copenhagen, Denmark.
Mannix S, Oko-Osi H, Gleeson S, Skalicky AM, Desai P, Sapra S, Bayliss M, Buse DC, Hareendran A. The Migraine Physical Function Impact Diary: Content Validity of a New Instrument to Evaluate the Benefit of Preventive Migraine Treatments. Presented at EHMTIC – 2016; September 15-18, 2016; Glasgow, UK.
Oko-osi H, Arnold B, Savic L, Desai P, Hareendran A, Mannix S, Sapra S, Eremenco S. Translation and Linguistic Validation of the Migraine Physical Function Impact Diary (MPFID) for Use in 25 Countries. Presented at ISOQOL 2016 23rd Annual Conference; October 19-22, 2016; Copenhagen, Denmark.
Roberts L, Oko-Osi H, Hareendran A, Mannix S, Desai P, Sapra S. Methods for Addressing Challenges for Evaluating Patient-Reported Outcomes in Clinical Trials of Prophylactic Treatments for Migraines. Presented at AHS 2016; June 9-12, 2016; San Diego, CA, USA.
Shaffer S, Eremenco S, Hwang S, Evans C, Dallabrida S, Savalia M, Hareendran A, Sapra S, Desai P. The Migraine Physical Function Impact Diary (MPFID): Usability Testing of an Electronic Patient Assessment Tool. Presented at EHMTIC – 2016; September 15-18, 2016; Glasgow, UK.
Skalicky A, Mannix S, Hareendran A, Corey-Lisle P, Widnell K, Buse DC, Desai P, Sapra S. Reflecting Patients’ Perspectives in Measuring Migraine-related Impacts on Functioning: A Qualitative Study with Migraine Patients. Presented at AHS 2016; June 9-12, 2016; San Diego, CA, USA.
Skalicky A, Mannix S, Hareendran A, Corey-Lisle P, Widnell K, Buse DC, Desai P, Sapra S. Reflecting Patients’ Perspectives in Measuring Migraine-related Impacts on Functioning: A Qualitative Study with Migraine Patients. Presented at AHS 2016; June 9-12, 2016; San Diego, CA, USA.
Mannix S, Oko-Osi H, Gleeson S, Skalicky AM, Desai P, Sapra S, Bayliss M, Buse DC, Hareendran A. The Migraine Physical Function Impact Diary: Content Validity of a New Instrument to Evaluate the Benefit of Preventive Migraine Treatments. Presented at EHMTIC – 2016; September 15-18, 2016; Glasgow, UK.
Kawata AK, Sapra S, Desai P, Ortmeier B, Gleeson S, Revicki D, Lipton RB, Bayliss M, Hareendran A. An Anchor-Based Approach to Define an Impaired Day in Migraine Patients Utilizing the Migraine Physical Function Impact Diary (MPFID). Presented at ISPOR 2016 19th Annual European Congress; October 29-November 2, 2016; Vienna, Austria.
Kawata AK, Hsieh R, Hareendran A, Bender R, Shaffer S, Sapra S, Desai P, Bayliss M, Buse DC, Revicki D. Psychometric Properties of the Migraine Physical Function Impact Diary (MPFID). Presented at ISOQOL 2016 23rd Annual Conference; October 19-22, 2016; Copenhagen, Denmark.
Oko-osi H, Arnold B, Savic L, Desai P, Hareendran A, Mannix S, Sapra S, Eremenco S. Translation and Linguistic Validation of the Migraine Physical Function Impact Diary (MPFID) for Use in 25 Countries. Presented at ISOQOL 2016 23rd Annual Conference; October 19-22, 2016; Copenhagen, Denmark.
Shaffer S, Eremenco S, Hwang S, Evans C, Dallabrida S, Savalia M, Hareendran A, Sapra S, Desai P. The Migraine Physical Function Impact Diary (MPFID): Usability Testing of an Electronic Patient Assessment Tool. Presented at EHMTIC – 2016; September 15-18, 2016; Glasgow, UK.
Roberts L, Oko-Osi H, Hareendran A, Mannix S, Desai P, Sapra S. Methods for Addressing Challenges for Evaluating Patient-Reported Outcomes in Clinical Trials of Prophylactic Treatments for Migraines. Presented at AHS 2016; June 9-12, 2016; San Diego, CA, USA.
Hareendran A, Buse DC, Lipton RB, Bayliss MS, Mikol DD, Revicki DA, Zhang F, Desai P, Picard H, Kawata AK. Reducing Impaired Days: Results from the STRIVE Trial, A Phase 3, Randomized, Double-Blind Study of Erenumab for Episodic Migraine. Presented at IHC 2017; September 7-10, 2017; Vancouver, Canada.
Hareendran A, Buse DC, Lipton RB, Bayliss MS, Mikol DD, Revicki DA, Zhang F, Desai P, Picard H, Kawata AK. Reducing Impaired Days: Results from the STRIVE Trial, a Phase 3, Randomised, Double-Blind Study of Erenumab for Episodic Migraine. Presented at Headache Federation European Congress – 2017; December 1-3, 2017; Rome, Italy.
Kawata AK, Hareendran A, Poon JL, Thach AV, Desai P, Kubo Y, Mikol DD, Dodick DW, Lipton RB, Tepper SJ. Evaluating Clinically Meaningful Within-Subject Change in Functioning Associated with Migraine Prevention Using the Migraine Physical Function Impact Diary (MPFID). Presented at IHC 2017; September 7-10, 2017; Vancouver, Canada.
Kawata AK, Hareendran A, Poon JL, Thach A, Desai P, Kubo Y, Mikol DD, Dodick DW, Lipton RB, Tepper SJ. Evaluating Clinically Meaningful Within-Subject Change in Functioning Associated with Migraine Prevention Using the Migraine Physical Function Impact Diary (MPFID). Presented at Headache Federation European Congress – 2017; December 1-3, 2017; Rome, Italy.
Kawata AK, Hsieh R, Hareendran A, Bender R, Shaffer S, Sapra S, Desai P, Widnell K, Bayliss M, Buse DC, Revicki DA. Evaluating the Measurement Properties of a New Instrument — The Migraine Physical Function Impact Diary (MPFID). Poster presented at American Academy of Neurology (AAN); April 22–28, 2017; Boston, MA, USA.
Kawata AK, Hareendran A, Shaffer S, Mannix S, Sapra S, Desai P, Ortmeier BG, Lipton RB, Dodick DW and Stewart WF. The Impact of Migraine on Physical Functioning in Adults with Chronic and Episodic Migraine. Presented at AHS 2017; June 8-11, 2017; Boston, MA, USA.
Goadsby PJ, Reuter U, Bonner J, Broessner G, Hallstrom Y, Zhang F, Sapra S, Picard H, Mikol DD, Lenz R. Phase 3, Randomized, Double-Blind, Placebo-Controlled STudy to Evaluate the Efficacy and Safety of Erenumab in migRaIne PreVEntion: Primary Results of the STRIVE Trial. Poster presented at: American Academy of Neurology (AAN) Annual Meeting; April 22-28, 2017; Boston, MA, USA.
Lipton LB, Buse DC, Dodick DW, Tepper SJ, Goadsby PJ, Kawata AK, Hareendran A, Sapra S, Desai P, Mikol DD. Measuring the Impact of Migraine on Days Before, During, and After a Migraine Using the Migraine Physical Function Impact Diary (MPFID). American Headache Society 60th Annual Conference 2018; June 28-July 1, 2018; San Francisco, CA, USA.